Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort (HSC# 004789)

NCT01816880 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.

NCT NCT01816880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01816880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort (HSC# 004789)
Lead sponsor
Scripps Translational Science Institute
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
May 31, 2015
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibodies involved in healthy aging